Ali Iranmanesh
Endocrinology, Diabetes & Metabolism · Salem, VANPI 1659303188
Payments from drug & device makers
$1,102,843in general payments, 2019–2025
Across 856 payments — averaging $1288.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$403K
- Novo Nordisk AS$337K
- AbbVie$176K
- Pfizer$100K
- AstraZeneca$70K
- Sanofi US Services Inc.$14K
- plus $3K from 1 others
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 180 | $402,833 |
| Novo Nordisk AS | 604 | $336,905 |
| AbbVie | 45 | $175,542 |
| Pfizer | 21 | $99,602 |
| AstraZeneca | 4 | $70,268 |
| Sanofi US Services Inc. | 1 | $14,323 |
| Sanofi-aventis U.S. LLC | 1 | $3,370 |
How this compares
$1,102,843 in reported general payments places this provider in the 95th percentile of 223 endocrinology, diabetes & metabolism providers in Virginia.
See all endocrinology, diabetes & metabolism providers in Virginia →
Other endocrinology, diabetes & metabolism in Salem
- Domenica RubinoArlington$3M
- Suzanne Jan de BeurCharlottesville$1.5M
- Farhad ZangenehSterling$1.2M
- Elias SirajNorfolk$884K
- James MulindaRoanoke$788K
- Jeffrey SicatGlen Allen$657K
- Dewey BaileyRoanoke$645K
- James la RocqueChesapeake$576K
- Samamtha HudsonMidlothian$372K
- Stacey AndersonCharlottesville$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.